By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Waters today announced that its board has approved a plan to repurchase up to $500 million of its outstanding common shares over the next 24 months.

The board gave its approval on Wednesday. Purchases will be made through open market transactions. The company recently completed a $500 million stock repurchase program that was announced in February 2009.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.